Teleflex (TFX) is moving up as investors react to an SEC-filed update on its planned business divestitures. The company disclosed that the Hart-Scott-Rodino (HSR) waiting period for the sale of its Original Equipment and Manufacturing and Development Services (OEM) business expired at 11:59 p.m. ET on March 13, 2026, satisfying a key closing condition and supporting the company’s expected closing timeline in the third quarter of 2026. (stocktitan.net)

In the same filing, Teleflex said the separate transaction to sell its Acute Care and Interventional Urology businesses received Federal Trade Commission Second Requests on March 11, 2026, which extends the HSR waiting period until 30 days after both parties substantially comply. Teleflex continues to expect that transaction to close in the second half of 2026, but the Second Request process can lengthen the timeline and increase uncertainty. (stocktitan.net)

With Teleflex in the middle of a major portfolio reset, incremental deal-progress signals can move the stock because they affect timing, confidence in completion, and the path to a slimmer post-divestiture company. The OEM HSR milestone reduces one regulatory gating item for that transaction, even as investors continue to watch the FTC’s deeper review of the other divestiture. (stocktitan.net)